Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-27T15:02:29.202Z Has data issue: false hasContentIssue false
  • English
  • Français

Olanzapine Versus Haloperidol: Results of the Multi-center International Trial

Published online by Cambridge University Press:  16 April 2020

Douglas J. Williamson ,
Charles M. Beasley ,
Pierre V. Tran ,
Roy N. Tamura ,
Todd M. Sanger  and
Gary D. Tollefson
Douglas J. Williamson
Affiliation:
Lilly Industries Ltd, Dextra Court, Chapel Hill, Basingstoke, RG21 5SY, UK
Charles M. Beasley
Affiliation:
Olanzapine Development Team, Lilly Research Laboratories, Indianapolis, IN, 46285, UK
Pierre V. Tran
Affiliation:
Olanzapine Development Team, Lilly Research Laboratories, Indianapolis, IN, 46285, UK
Roy N. Tamura
Affiliation:
Olanzapine Development Team, Lilly Research Laboratories, Indianapolis, IN, 46285, UK
Todd M. Sanger
Affiliation:
Olanzapine Development Team, Lilly Research Laboratories, Indianapolis, IN, 46285, UK
Gary D. Tollefson
Affiliation:
Olanzapine Development Team, Lilly Research Laboratories, Indianapolis, IN, 46285, UK

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Symposia
Information
European Psychiatry , Volume 11 , Issue S4: European psychiatry: a force for the future - 8th Congress of Association of European Psychiatrists and Annual Meeting of the Royal College of Psychiatrists , 1996 , pp. 202s - 203s
Copyright
Copyright © Elsevier Paris 1996
Submit a response

Comments

No Comments have been published for this article.